Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura Gault
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 7536
Little Rock, Arkansas, United States
- Site Reference Id/investigator# 7954
Bradenton, Florida, United States
- Site Reference Id/investigator# 7543
Jacksonville, Florida, United States
- Site Reference Id/investigator# 7542
Orlando, Florida, United States
- Site Reference Id/investigator# 7537
Libertyville, Illinois, United States
- Site Reference Id/investigator# 7561
Overland Park, Kansas, United States
- Site Reference Id/investigator# 7560
Troy, Michigan, United States
- Site Reference Id/investigator# 7559
Omaha, Nebraska, United States
- Site Reference Id/investigator# 7541
Las Vegas, Nevada, United States
- Site Reference Id/investigator# 7564
Oklahoma City, Oklahoma, United States
- Site Reference Id/investigator# 7538
Portland, Oregon, United States
- Site Reference Id/investigator# 7540
Memphis, Tennessee, United States
- Site Reference Id/investigator# 7544
Bellevue, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 31 Jul 2008
- Completion
- 31 Jul 2008
- Last update posted
- 18 Jan 2013
- Registered enrollment
- 121
- Registry id
- NCT00640419
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.